Electrophysiologic Mechanisms of Ketamine Antidepressant Response
Public ClinicalTrials.gov record NCT07768618. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Electrophysiologic Dynamics of Depression and Antidepressant Response in Epilepsy
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study aims to identify electrophysiologic biomarkers associated with antidepressant response to ketamine in adults with epilepsy undergoing clinically indicated stereo-electroencephalography (sEEG) monitoring who have at least mild depressive symptoms. Participants will receive a single subanesthetic intravenous ketamine infusion (0.5 mg/kg over 40 minutes) during their Epilepsy Monitoring Unit admission. Intracranial neural recordings and behavioral assessments will be collected before and approximately 24 hours after infusion to examine changes in neural circuits associated with rumination and anhedonia.
Study identification
- NCT ID
- NCT07768618
- Recruitment status
- Not yet recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 37 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 30, 2026
- Primary completion
- Nov 30, 2031
- Completion
- Nov 30, 2031
- Last update posted
- Aug 16, 2026
2026 – 2031
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Emory University | Atlanta | Georgia | 30322 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Depressive Symptoms trials
Other public records listing Depressive Symptoms. Sorted by last update posted; newest first. Not a recommendation.
- NCT05567640: Using Machine Learning to Optimize User Engagement and Clinical Response to Digital Mental Health Interventions Recruiting
- NCT07717385: Sleep More, Stress Less: 90-Day Trial of Neuralli Mood Recruiting
- NCT05585775: Mood and Thought Process Study Active, not recruiting
- NCT07020572: Improving Mood for Adolescents Through Teaming With End-Users in Routine Care (The iMATTER Project) Recruiting
- NCT06574035: Michigan Men's Diabetes Project III(MenDIII): Mind and Motion Recruiting
- NCT06085313: Cancer Pain Management Using a Web-based Intervention Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07768618, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 16, 2026 · Synced Aug 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07768618 live on ClinicalTrials.gov.